Notably, by comparing the immune responses between IDH-1 MUT and IDH-1 WT patients, some studies have identified a marked reduction in the expression of immune-related genes, including the CD274 (PD-L1 coding gene) gene, in IDH-1 MUT gliomas (25–27). The gene discussed is IDH1; the disease is central nervous system cancer.